Otsuka Of Japan Acquires Interpharma Praha Of Czech Republic
This article was originally published in PharmAsia News
Executive Summary
Japan's Otsuka Pharmaceutical says it has acquired the Czech Republic company Interpharma Praha and its expertise in contrast agents for X-rays. The agents would comprise a new product line for Otsuka in a segment of the market that is growing along with the global popularity of CT scans. Otsuka plans to use Interpharma in an effort to expand its presence in Europe, but plans to concentrate on selling the contrast agents in Russia. Interpharma had more than $9.1 million in sales in fiscal 2007. (Click here for more - a subscription may be required